Patent ID: 7645755
Filing Date: 2010-01-12
Classification: A61K,C07D

Abstract:
1. A compound selected from the group consisting of: 5-Cyano-1H-imidazole-2-carboxylic acid [4-(3,6-dihydro-2H-pyran-4-yl)-2-(4,4-dimethyl-cyclohex-1-enyl)-phenyl]-amide; 4-Cyano-1H-imidazole-2-carboxylic acid {2-cyclohept-1-enyl-4-[1-(2-dimethylamino-acetyl) -piperidin-4-yl]-phenyl}-amide trifluoroacetic acid salt; 4-Cyano-1H-imidazole-2-carboxylic acid [4-[1-(2-dimethylamino-acetyl)-piperidin-4-yl]-2-(4,4-dimethyl-cyclohex-1-enyl)-phenyl]-amide trifluoroacetic acid salt; 4-Cyano-1H-pyrrole-2-carboxylic acid {2-cyclohex-1-enyl-4-[1-(2-dimethylamino-acetyl) -piperidin-4-yl]-phenyl}-amide trifluoroacetic acid salt; 4-Cyano-1-imidazole-2-carboxylic acid {2-(4,4-dimethyl-cyclohex-1-enyl)-4-[1-(2-methanesulfonyl-ethyl)-piperidin-4-yl]-phenyl}-amide trifluoroacetic acid salt; and tautomers and pharmaceutically acceptable salts thereof.